Home
/
Hoth Therapeutics, Inc.
/
Financials
/
Quarterly
Hoth Therapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Hoth Therapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2024
Mar 31, 2024
$1.24B
May 14, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($4.11M)
Nov 12, 2025
Q3
2025
Jun 30, 2025
($2.20M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($2.20M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($3.48M)
May 12, 2025
Q3
2025
Mar 31, 2025
($3.48M)
Nov 12, 2025
Q2
2025
Mar 31, 2025
($3.48M)
Aug 12, 2025
Q3
2025
Sep 30, 2024
($2.23M)
Nov 12, 2025
Q3
2025
Jun 30, 2024
($1.71M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($1.71M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($2.15M)
May 12, 2025
Q2
2025
Mar 31, 2024
($2.15M)
Aug 12, 2025
Q3
2025
Mar 31, 2024
($2.15M)
Nov 12, 2025
Q3
2024
Sep 30, 2023
($2.09M)
Nov 12, 2024
Q3
2024
Jun 30, 2023
($1.87M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($1.87M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($2.18M)
May 14, 2024
Q2
2024
Mar 31, 2023
($2.18M)
Aug 9, 2024
Q3
2024
Mar 31, 2023
($2.18M)
Nov 12, 2024
Q3
2023
Sep 30, 2022
($2.64M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($2.68M)
Aug 11, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($4.08M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($2.20M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($3.48M)
May 12, 2025
Q3
2025
Sep 30, 2024
($2.23M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($1.72M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($2.16M)
May 12, 2025
Q3
2024
Sep 30, 2023
($2.09M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($1.71M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($2.19M)
May 14, 2024
Q3
2023
Sep 30, 2022
($2.68M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($2.30M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($2.66M)
May 15, 2023
Q3
2022
Sep 30, 2021
($3.25M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($3.20M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($4.27M)
May 12, 2022
Q3
2021
Sep 30, 2020
($2.17M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($2.52M)
Aug 11, 2021
Q1
2021
Mar 31, 2020
($1.82M)
May 13, 2021
Q3
2020
Sep 30, 2019
($1.70M)
Nov 10, 2020
Q2
2020
Jun 30, 2019
($1.27M)
Aug 13, 2020